Trust Company’s Eli Lilly LLY Stock Holding History

Trust Company’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$603K	Sell	503 -1,929	-79%	-$1.97M	0.05%	95
2026 Q1	$2.24M	Buy	2,432 +33	+1%	+$33.5K	0.21%	51
2025 Q4	$2.58M	Buy	2,399 +1,952	+437%	+$1.87M	0.24%	45
2025 Q3	$341K	Hold	447	–	–	0.03%	111
2025 Q2	$348K	Hold	447	–	–	0.04%	112
2025 Q1	$369K	Hold	447	–	–	0.04%	105
2024 Q4	$345K	Hold	447	–	–	0.04%	112
2024 Q3	$396K	Hold	447	–	–	0.05%	100
2024 Q2	$405K	Sell	447 -3	-0.7%	-$2.4K	0.05%	96
2024 Q1	$350K	Hold	450	–	–	0.05%	97
2023 Q4	$262K	Buy	450 +422	+1,507%	+$246K	0.03%	118
2023 Q3	$15K	Sell	28 -219	-89%	-$113K	﹤0.01%	253
2023 Q2	$116K	Sell	247 -891	-78%	-$374K	0.02%	157
2023 Q1	$391K	Sell	1,138 -30	-3%	-$10.1K	0.06%	105
2022 Q4	$427K	Buy	1,168 +30	+3%	+$10.6K	0.07%	100
2022 Q3	$368K	Sell	1,138 -4	-0.4%	-$1.27K	0.08%	96
2022 Q2	$370K	Buy	1,142 +4	+0.4%	+$1.2K	0.08%	100
2022 Q1	$326K	Hold	1,138	–	–	0.06%	108
2021 Q4	$314K	Hold	1,138	–	–	0.07%	95
2021 Q3	$263K	Hold	1,138	–	–	0.07%	99
2021 Q2	$261K	Hold	1,138	–	–	0.18%	93
2021 Q1	$213K	Hold	1,138	–	–	0.15%	105
2020 Q4	$192K	Hold	1,138	–	–	0.15%	106
2020 Q3	$168K	Hold	1,138	–	–	0.14%	111
2020 Q2	$187K	Hold	1,138	–	–	0.18%	96
2020 Q1	$158K	Hold	1,138	–	–	0.17%	81
2019 Q4	$150K	Hold	1,138	–	–	0.13%	102
2019 Q3	$127K	Hold	1,138	–	–	0.12%	101
2019 Q2	$126K	Hold	1,138	–	–	0.12%	104
2019 Q1	$148K	Hold	1,138	–	–	0.09%	103
2018 Q4	$132K	Sell	1,138 -25	-2%	-$2.79K	0.07%	92
2018 Q3	$125K	Sell	1,163 -150	-11%	-$15K	0.06%	100
2018 Q2	$112K	Sell	1,313 -90	-6%	-$7.39K	0.05%	113
2018 Q1	$109K	Hold	1,403	–	–	0.04%	115
2017 Q4	$118K	Hold	1,403	–	–	0.05%	102
2017 Q3	$120K	Sell	1,403 -200	-12%	-$16.4K	0.07%	91
2017 Q2	$132K	Sell	1,603 -105	-6%	-$8.57K	0.06%	104
2017 Q1	$144K	Hold	1,708	–	–	0.07%	113
2016 Q4	$126K	Hold	1,708	–	–	0.06%	117
2016 Q3	$137K	Hold	1,708	–	–	0.06%	126
2016 Q2	$135K	Hold	1,708	–	–	0.05%	125
2016 Q1	$123K	Hold	1,708	–	–	0.06%	124
2015 Q4	$144K	Sell	1,708 -81	-5%	-$6.72K	0.07%	106
2015 Q3	$150K	Buy	1,789 +549	+44%	+$46.3K	0.09%	95
2015 Q2	$104K	Buy	1,240 +100	+9%	+$7.62K	0.07%	142
2015 Q1	$83K	Buy	+1,140	New	+$81.2K	0.05%	134

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Trust Company's LLY Position: Q2 2026 in Review

Trust Company reduced its Eli Lilly (LLY) stake by 79% in Q2 2026, selling an estimated $1.97M and leaving 503 shares worth $603K. The position accounts for 0.05% of the portfolio, ranked #95.

Trust Company first reported a position in LLY in Q1 2015 and has held it in 46 quarters since. The position peaked at $2.58M in Q4 2025. 1,842 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Trust Company held 503 shares of Eli Lilly worth $603K as of Q2 2026.
Trust Company sold 1,929 Eli Lilly shares in Q2 2026, an estimated $1.97M.
Eli Lilly made up 0.05% of Trust Company's portfolio in Q2 2026, its #95 holding.
Trust Company first reported a position in Eli Lilly in Q1 2015 and has held it in 46 quarters since.
Trust Company's Eli Lilly position peaked at $2.58M in Q4 2025.
1,842 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.